136 related articles for article (PubMed ID: 36154601)
1. Acarbose Potentially Binds to the Type I Peptide Deformylase Catalytic Site and Inhibits Bacterial Growth: An
Singh AK; Prajapati KS; Kumar S
Curr Pharm Des; 2022; 28(35):2890-2900. PubMed ID: 36154601
[TBL] [Abstract][Full Text] [Related]
2. Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs.
Gao J; Liang L; Zhu Y; Qiu S; Wang T; Zhang L
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428963
[TBL] [Abstract][Full Text] [Related]
3. Theoretical study of Escherichia coli peptide deformylase inhibition by several drugs.
Chikhi A; Bensegueni A; Boulahrouf A; Bencharif M
In Silico Biol; 2006; 6(5):459-66. PubMed ID: 17274774
[TBL] [Abstract][Full Text] [Related]
4. Peptide deformylase inhibitors with non-peptide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Lee JS; Park JY; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2011 Jan; 21(1):133-6. PubMed ID: 21146987
[TBL] [Abstract][Full Text] [Related]
5. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
Chen DZ; Patel DV; Hackbarth CJ; Wang W; Dreyer G; Young DC; Margolis PS; Wu C; Ni ZJ; Trias J; White RJ; Yuan Z
Biochemistry; 2000 Feb; 39(6):1256-62. PubMed ID: 10684604
[TBL] [Abstract][Full Text] [Related]
6. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
Jain R; Chen D; White RJ; Patel DV; Yuan Z
Curr Med Chem; 2005; 12(14):1607-21. PubMed ID: 16022661
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor.
Clements JM; Beckett RP; Brown A; Catlin G; Lobell M; Palan S; Thomas W; Whittaker M; Wood S; Salama S; Baker PJ; Rodgers HF; Barynin V; Rice DW; Hunter MG
Antimicrob Agents Chemother; 2001 Feb; 45(2):563-70. PubMed ID: 11158755
[TBL] [Abstract][Full Text] [Related]
8. A peptide deformylase-ribosome complex reveals mechanism of nascent chain processing.
Bingel-Erlenmeyer R; Kohler R; Kramer G; Sandikci A; Antolić S; Maier T; Schaffitzel C; Wiedmann B; Bukau B; Ban N
Nature; 2008 Mar; 452(7183):108-11. PubMed ID: 18288106
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of Vanillin Hydroxamic Acid Derivatives as Novel Peptide Deformylase Inhibitors.
Gao J; Qiu S; Liang L; Hao Z; Zhou Q; Wang F; Mou J; Lin Q
Curr Comput Aided Drug Des; 2018; 14(1):95-101. PubMed ID: 28606047
[TBL] [Abstract][Full Text] [Related]
10. Delineation of alternative conformational states in Escherichia coli peptide deformylase via thermodynamic studies for the binding of actinonin.
Berg AK; Srivastava DK
Biochemistry; 2009 Feb; 48(7):1584-94. PubMed ID: 19191548
[TBL] [Abstract][Full Text] [Related]
11. Ligand-induced changes in the structure and dynamics of Escherichia coli peptide deformylase.
Amero CD; Byerly DW; McElroy CA; Simmons A; Foster MP
Biochemistry; 2009 Aug; 48(32):7595-607. PubMed ID: 19627112
[TBL] [Abstract][Full Text] [Related]
12. Biphenyl tetrazole-thiazolidinediones as novel bacterial peptide deformylase inhibitors: Synthesis, biological evaluations and molecular docking study.
Khan FAK; Jadhav KS; Patil RH; Shinde DB; Arote RB; Sangshetti JN
Biomed Pharmacother; 2016 Oct; 83():1146-1153. PubMed ID: 27551762
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
Yang S; Shi W; Xing D; Zhao Z; Lv F; Yang L; Yang Y; Hu W
Eur J Med Chem; 2014 Oct; 86():133-52. PubMed ID: 25151577
[TBL] [Abstract][Full Text] [Related]
14. Virtual Screening Approach of Bacterial Peptide Deformylase Inhibitors Results in New Antibiotics.
Merzoug A; Chikhi A; Bensegueni A; Boucherit H; Okay S
Mol Inform; 2018 Mar; 37(3):. PubMed ID: 28991412
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of time-dependent inhibition of polypeptide deformylase by actinonin.
Van Aller GS; Nandigama R; Petit CM; DeWolf WE; Quinn CJ; Aubart KM; Zalacain M; Christensen SB; Copeland RA; Lai Z
Biochemistry; 2005 Jan; 44(1):253-60. PubMed ID: 15628866
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cobalt(II)-substituted peptide deformylase: function of the metal ion and the catalytic residue Glu-133.
Rajagopalan PT; Grimme S; Pei D
Biochemistry; 2000 Feb; 39(4):779-90. PubMed ID: 10651644
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of peptide deformylase inhibitors.
Huntington KM; Yi T; Wei Y; Pei D
Biochemistry; 2000 Apr; 39(15):4543-51. PubMed ID: 10758004
[TBL] [Abstract][Full Text] [Related]
18. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
[TBL] [Abstract][Full Text] [Related]
19. Bacterial Peptide Deformylase Inhibition of Tetrazole-Substituted Biaryl Acid Analogs: Synthesis, Biological Evaluations, and Molecular Docking Study.
Khan FA; Patil RH; Patil M; Arote R; Shinde DB; Sangshetti JN
Arch Pharm (Weinheim); 2016 Dec; 349(12):934-943. PubMed ID: 27859538
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a human peptide deformylase: implications for antibacterial drug design.
Nguyen KT; Hu X; Colton C; Chakrabarti R; Zhu MX; Pei D
Biochemistry; 2003 Aug; 42(33):9952-8. PubMed ID: 12924944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
